Pulsenmore Selected for Israel Healthcare AI Sandbox With IIA Funding
Jul 13, 2026, 7:03 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Positive regulatory support and high-profile hospital collaboration can de-risk AI component development and potentially expand addressable market; however, immediate revenue remains uncertain, so gains may be gradual.
AI summary
What happened, with direct paths to the underlying reporting
Pulsenmore was selected for Israel's Healthcare AI Regulatory Sandbox, receiving funding from the Israel Innovation Authority. The program aims to accelerate AI-enabled clinical validation and adoption of Pulsenmore's home ultrasound platform, leveraging a 250,000-scan dataset and Beilinson/Clalit partnerships to expand physician workflow efficiencies.
Pulsenmore selected for Israel's Healthcare AI Regulatory Sandbox; IIA funding.
Sandbox aims to accelerate AI-enabled clinical validation and adoption.
250,000 home ultrasound scans performed; world's largest real-world prenatal dataset.
Beilinson Hospital to collaborate; Clalit Health Services deployment anchor.
AI workflow improvements to reduce review time and expand patient reach.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event